These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27608899)

  • 81. Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer.
    Xiao J; Xu X; Li X; Li Y; Liu G; Tan H; Shen H; Shi H; Cheng D
    Molecules; 2016 Sep; 21(10):. PubMed ID: 27706035
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report.
    Tani T; Naoki K; Asakura T; Hirano T; Suzuki S; Masuzawa K; Hasegawa H; Kuroda A; Yasuda H; Ishii M; Soejima K; Betsuyaku T
    Mol Clin Oncol; 2016 Oct; 5(4):488-490. PubMed ID: 27699048
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea.
    Tremblay G; Majethia U; Breeze JL; Kontoudis I; Park J
    Clinicoecon Outcomes Res; 2016; 8():485-493. PubMed ID: 27698565
    [TBL] [Abstract][Full Text] [Related]  

  • 84. PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Wirth LJ; Dakhil S; Kornek G; Axelrod R; Adkins D; Pant S; O'Brien P; Debruyne PR; Oliner KS; Dong J; Murugappan S
    Oral Oncol; 2016 Oct; 61():31-40. PubMed ID: 27688102
    [TBL] [Abstract][Full Text] [Related]  

  • 85. RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.
    Fumagalli D; Venet D; Ignatiadis M; Azim HA; Maetens M; Rothé F; Salgado R; Bradbury I; Pusztai L; Harbeck N; Gomez H; Chang TW; Coccia-Portugal MA; Di Cosimo S; de Azambuja E; de la Peña L; Nuciforo P; Brase JC; Huober J; Baselga J; Piccart M; Loi S; Sotiriou C
    JAMA Oncol; 2017 Feb; 3(2):227-234. PubMed ID: 27684533
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells.
    Zhang W; Chen L; Ma K; Zhao Y; Liu X; Wang Y; Liu M; Liang S; Zhu H; Xu N
    Oncotarget; 2016 Nov; 7(46):75366-75378. PubMed ID: 27683110
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Appendicitis caused by the metastasis of HER2-positive breast cancer.
    Mori R; Futamura M; Morimitsu K; Yoshida K
    Surg Case Rep; 2016 Dec; 2(1):104. PubMed ID: 27683008
    [TBL] [Abstract][Full Text] [Related]  

  • 88. An antidote to fluorouracil and capecitabine toxicity.
    Wilkinson E
    Lancet Oncol; 2016 Oct; 17(10):e429. PubMed ID: 27667571
    [No Abstract]   [Full Text] [Related]  

  • 89. Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives.
    Schettini F; Giuliano M; De Placido S; Arpino G
    Cancer Treat Rev; 2016 Nov; 50():129-141. PubMed ID: 27665540
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Brain metastases from breast cancer during pregnancy.
    Sharma A; Nguyen HS; Lozen A; Sharma A; Mueller W
    Surg Neurol Int; 2016; 7(Suppl 23):S603-6. PubMed ID: 27656319
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trial.
    Sousa N; Sousa O; Santos LL; Henrique R; Teixeira MR; Dinis-Ribeiro M; Teixeira-Pinto A
    Trials; 2016 Sep; 17(1):459. PubMed ID: 27655166
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.
    Du F; Yuan P; Zhao ZT; Yang Z; Wang T; Zhao JD; Luo Y; Ma F; Wang JY; Fan Y; Cai RG; Zhang P; Li Q; Song YM; Xu BH
    Sci Rep; 2016 Sep; 6():33825. PubMed ID: 27650797
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of the Therapeutic Efficacy of the Early and the Delayed Use of Vinorelbine-Based Regimens for Patients with Advanced Breast Cancer.
    Wang Y; Liu J; Jia W; Li S; Rao N; Su F; Liu Q; Yao H
    Chemotherapy; 2017; 62(1):71-79. PubMed ID: 27648841
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Afatinib down-regulates MCL-1 expression through the PERK-eIF2α-ATF4 axis and leads to apoptosis in head and neck squamous cell carcinoma.
    Liu X; Lv Z; Zou J; Liu X; Ma J; Wang J; Sa N; Jing P; Xu W
    Am J Cancer Res; 2016; 6(8):1708-19. PubMed ID: 27648360
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Relationship between treatment-related hypertension and therapeutic efficacy of vascular endothelial growth factor receptor tyrosine kinase inhibitors in metastatic renal cell carcinoma].
    Song Y; Du CX; Zhang W; Sun YK; Yang L; Cui CX; Chi Y; Zhou AP; Wang JW; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):698-702. PubMed ID: 27647404
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rectal cancer: Neoadjuvant chemoradiotherapy.
    Rödel C; Hofheinz R; Fokas E
    Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):629-39. PubMed ID: 27644910
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel.
    Li K; Mao Y; Lu L; Hu C; Wang D; Si-Tu J; Lu M; Peng S; Qiu J; Gao X
    Int J Oncol; 2016 Oct; 49(4):1679-85. PubMed ID: 27633058
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy.
    Hainsworth JD; Murphy PB; Alemar JR; Daniel BR; Young RR; Yardley DA
    Breast Cancer Res Treat; 2016 Nov; 160(1):41-49. PubMed ID: 27632289
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome.
    Lou Y; Wang Q; Zheng J; Hu H; Liu L; Hong D; Zeng S
    Chem Res Toxicol; 2016 Oct; 29(10):1591-1601. PubMed ID: 27631426
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.